U.S. Markets closed


Hamburg - Hamburg Delayed Price. Currency in EUR
Add to watchlist
106.85-1.22 (-1.13%)
At close: 11:56AM CEST
Full screen
Previous Close108.07
Bid0.00 x 0
Ask0.00 x 0
Day's Range106.85 - 107.57
52 Week Range103.65 - 123.59
Avg. Volume818
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reutersyesterday

    Bayer, J&J win third U.S. trial over Xarelto bleeding risk

    A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding. The verdict in U.S. District Court in Jackson, Mississippi, is a blow to thousands of patients with similar allegations against the drugmaker. In the latest case, plaintiff Dora Mingo claimed she suffered acute gastrointestinal bleeding after she was treated with Xarelto for a month in 2015 to prevent blood clotting following an operation.

  • The Wall Street Journal3 days ago

    [$$] Bayer Joins Fight Against Citrus Greening Disease

    Florida’s battered citrus industry is gaining a new partner in its decadelong fight against a disease ravaging the state’s groves: the German pharmaceutical and chemical giant Bayer.

  • Bayer-Backed Health Startup Medopad Raises Funds With UBS
    Bloomberg4 days ago

    Bayer-Backed Health Startup Medopad Raises Funds With UBS

    Medopad Ltd., backed by pharmaceuticals giant Bayer AG, is looking to raise new funds, joining the clutch of fast growing U.K. startups that are mixing artificial intelligence and health care.